Conferences - Results from #7840

FOIU 2018: Novel Targeted Androgen Ablation Prior to Radical Prostatectomy July 6, 2018

FOIU 2018: The Role of Radical Prostatectomy in Locally Advanced and Oligometastatic High Risk Prostate Cancer July 5, 2018

FOIU 2018: Optimizing the Management of High Risk Prostate Cancer with Radiotherapy July 5, 2018

FOIU 2018: Should the Primary Be Treated in Patients with Metastatic Disease? - Testicular Cancer July 5, 2018

FOIU 2018: Aggressive and Unusual Subtypes of Prostate Cancer July 5, 2018

FOIU 2018: Should the Primary Be Treated in Patients with Metastatic Disease? - Upper Tract Urothelial Cancer July 5, 2018

FOIU 2018: Should the Primary Be Treated in Patients with Metastatic Disease? - Kidney Cancer July 5, 2018

FOIU 2018: Bladder Cancer – Oncologist’s View July 5, 2018

FOIU 2018: Oncologist View - Local Treatment of Metastatic Prostate Cancer July 4, 2018

FOIU 2018: Should the Primary Be Treated in Patients with Metastatic Disease? - Prostate Cancer July 4, 2018

FOIU 2018: Does Checkpoint Inhibition Work in Prostate Cancer? July 4, 2018

FOIU 2018: Current Experience in Immunotherapy for Metastatic Renal Cell Carcinoma July 4, 2018

FOIU 2018: Immune-Oncology In Genitourinary Malignancies - Have We All Been Too Enthusiastic Too Soon? July 4, 2018

FOIU 2018: Current Experience in Immunotherapy for Metastatic Bladder Cancer July 4, 2018

FOIU 2018: Immunotherapy as an Early Treatment? What Have We Learned From Other Malignancies? July 4, 2018

FOIU 2018: Adjuvant Therapy for Locally Advanced and Node-positive Upper Tract UC July 3, 2018

FOIU 2018: Urothelial Carcinoma of the Upper Tract Following Radical Cystectomy July 3, 2018

FOIU 2018: Is There a Risk in Robotic Nephro-ureterctomy? July 3, 2018

FOIU 2018: Ureteoscopic Management of Upper Tract UC: Time to Update the Guidelines? July 3, 2018

FOIU 2018: Experience with MitoGel™ in Upper Tract Urothelial Carcinoma July 3, 2018

Page 393 of 620